Ideally, beneficiaries with schizophrenia or bipolar disorder should receive a continuous supply of evidence-based medications, psychosocial services, and laboratory monitoring of medication levels (for lithium and certain anticonvulsants) or common physical complications (for antipsychotics).
More than half (57 percent) of beneficiaries with schizophrenia had high medication continuity, and 45 percent also received at least one psychosocial service during the year. However, few received recommended screenings for cardiovascular disease and diabetes; taking these screenings into account, roughly 5 percent of beneficiaries with schizophrenia received all of these services during the year (Figure 1).
Forty-five percent of beneficiaries with bipolar disorder had high medication continuity, and 35 percent also received at least one psychosocial service. As was the case for beneficiaries with schizophrenia, few beneficiaries with bipolar disorder (about 5 percent) received all of these services.
FIGURE 1. Receipt of Multiple EBPs by Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder, 2007
SOURCE: MAX data, calendar year 2007.